2-(2-METHOXYPHENYL)-2-METHYLPROPANENITRILE, 95%, 500mg

2-Bromo-5-fluoro-4-nitroaniline, 95.0%, 5g

7-Bromo-2-methylimidazo[1,2-a]-pyridine-3-carboxylic acid, 97%, 1g

1-(benzenesulfonyl)-4-chloro-2-iodo-1H-pyrrolo[2,3-b]pyridine, 25g

Sulfanilamida, ROTI®Calipure, punto de fusión estándar 164-166 °C, 1 g, envase de vidrio

(R)-2-Ethylpiperidine hydrochloride, 95.0%, 500mg

Phenyl (4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)carbamate, 95.0%, 25g

Benzothiazole-2,6-diamine, 95.0%, 10g

Methyl Undecafluorohexanoate>96.0%(GC)5g

1,4-Diamino-2,3-dihydroanthracene-9,10-dione, 99%, 100g

[2-(8-quinolinyloxy)ethyl]amine dihydrochloride, 95.0%, 10g

5-Bromo-2-cyclopropylpyridine, 95.0%, 1g

(3aR,4S,5R,6aS)-4-(Hydroxymethyl)-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl Biphenyl-4-carboxylate, 98.0%, 1g